Heather Pierce
Nurse Practitioner · Pekin, ILNPI 1992330583
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $57,100 of the $72,078 with a category attached, or 79.2%. AstraZeneca accounts for 97.5% of it on its own, with 33 other manufacturers making up the rest. 2025 is the largest year on record at $29,333, 9.8 times the $2,991 reported in 2022. Among nurse practitioner clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $265.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$70K
- Novartis$186
- Seagen Inc.$173
- E.r. Squibb & Sons, L.L.C.$150
- AbbVie$138
- Bristol Myers Squibb$111
- plus $1K from 28 others
What the payments were for
- Consulting fees$8001%
- Speaking & faculty fees$57,10079%
- Travel & lodging$7,88711%
- Food & beverage$6,1919%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 182 | $70,256 |
| Novartis | 11 | $186 |
| Seagen Inc. | 5 | $173 |
| E.r. Squibb & Sons, L.L.C. | 4 | $150 |
| AbbVie | 6 | $138 |
| Bristol Myers Squibb | 4 | $111 |
| GSK | 5 | $92 |
| Merck | 5 | $81 |
| Pharmacyclics LLC, An Abbvie Company | 4 | $71 |
| Johnson & Johnson | 3 | $64 |
| Eisai Inc. | 3 | $64 |
| Incyte Corporation | 4 | $59 |
| Genentech USA, Inc. | 4 | $58 |
| Lilly USA, LLC | 3 | $57 |
| Bayer | 3 | $53 |
| Astellas Pharma US Inc | 3 | $48 |
| Daiichi Sankyo Inc. | 2 | $47 |
| Pfizer | 2 | $41 |
| G1 Therapeutics, Inc. | 2 | $33 |
| Servier Pharmaceuticals LLC | 2 | $32 |
| Organon | 1 | $30 |
| Sobi, Inc | 1 | $29 |
| AVEO Pharmaceuticals, Inc. | 1 | $29 |
| Mirati Therapeutics, Inc. | 1 | $22 |
| Beigene USA, Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Sanofi | 1 | $16 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Coherus Oncology, Inc. | 1 | $15 |
| Gilead | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| Boehringer Ingelheim | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$72,078 in reported general payments places this provider in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $7,519 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 65 | $1,195 |
| Fentanyl | 15 | $1,016 |
| Morphine Sulfate ErMorphine Sulfate | 12 | $262 |
| Anastrozole | 16 | $226 |
| Potassium Chloride | 16 | $162 |
| Lorazepam | 47 | $133 |
| Dexamethasone | 20 | $86 |
| Ondansetron Hcl | 17 | $58 |
| Azithromycin | 13 | $53 |
| Levofloxacin | 14 | $50 |
| Tramadol Hcl | 14 | $41 |
| Olanzapine | 12 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $41 | $7,51911 claims |
| Lilly USA, LLCOlanzapine | $57 | $2512 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,869 nurse practitioner providers in Illinois.
Other nurse practitioner in Pekin
- Deepa VallikatWest Dundee$332K
- Maria MalotoNaperville$135K
- Valerie LaroyOak Lawn$112K
- Jennifer LiebChampaign$109K
- Tanya MungerRockford$106K
- Erika VuckoChicago$76K
- Yvonna OldakerFlossmoor$74K
- Dara McKinleyEvanston$66K
- Kristine WarnesNaperville$66K
- Michelle MunroeChicago$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.